Episode 10: Paul-Peter Tak, Academic, business leader and biotech entrepreneur

episode

TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Q+A: The hidden risks as accountants embrace AI 10 min · 23 Sep 2026 · FEAR & GREED | Business News

Al Leiter and Harold Reynolds: Old School Baseball, Lost Art of Pitching, Nearly Fighting David Ortiz 1h 37m · 23 Sep 2026 · All The Smoke

Wednesday Morning Vice with Lola Vice & Dolph Lundgren 32 min · 23 Sep 2026 · Busted Open

Morgan Stanley email exposes deal secrets 3 min · 23 Sep 2026 · Wall Street Breakfast

Dark Patterns: How to Escape the Subscription Trap 15 min · 23 Sep 2026 · Making Cents

The Greatest Sports Photo of All-Time | Postgame Show 12 min · 23 Sep 2026 · The Dan Le Batard Show

Report any issue

Source

Recorded26 Aug 2020

Publisherfeed.podbean.com ↗

Handlerec:2095178

Show notes

In this episode, Paul-Peter Tak joins Monica Westley to discuss his innovative ideas within the type 1 diabetes space and how immunology can play a role in helping find a cure for T1D. Paul-Peter is an immunologist, academic, and venture partner who has specialized in the fields of rheumatology and immunology. Paul-Peter Tak- "I think the future is clearly in looking at type 1 diabetes in a different way. I would almost reclassify it (as an immunologist, not necessarily as a diabetes expert) and I would call it pancreatic autoimmunity."

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in